Viperin controls chikungunya virus-specific pathogenic T cell IFNγ Th1 stimulation in mice.
Guillaume CarissimoTeck-Hui TeoYi-Hao ChanCheryl Yi-Pin LeeBernett LeeAnthony Torres-RuestaJeslin Jl TanTze-Kwang ChuaSiew-Wai FongFok-Moon LumLisa F P NgPublished in: Life science alliance (2019)
Chikungunya virus (CHIKV) has been a worldwide threat since its reemergence in La Reunion Island in 2004. Expression of the interferon-stimulated protein Viperin correlates with viral load burden in patients, and studies in mice have demonstrated its role to limit disease severity against CHIKV infection. Using Viperin -/- mice, we aimed to understand the contribution of Viperin to the T-cell immune response against CHIKV. CD4 T-cell depletion in Viperin -/- mice showed that increased late acute joint inflammation (5-8 d postinfection) was exclusively mediated by T cells. Specifically, CHIKV-infected Viperin -/- mice showed an increased INFγ Th1 profile of CD4 T cells, enhanced INFγ stimulation by APCs, an increased INFγ secretion profile in the joint microenvironment, and increased numbers of inflammatory monocytes in virus-infected joints compared with WT mice. Bone marrow grafting experiments showed that Viperin expression in both hematopoietic and non-hematopoietic cells is instrumental in reducing disease severity associated with a CD4 T-cell response.
Keyphrases
- bone marrow
- high fat diet induced
- immune response
- poor prognosis
- dendritic cells
- stem cells
- oxidative stress
- end stage renal disease
- mesenchymal stem cells
- induced apoptosis
- wild type
- metabolic syndrome
- chronic kidney disease
- binding protein
- insulin resistance
- intensive care unit
- skeletal muscle
- long non coding rna
- prognostic factors
- peritoneal dialysis
- peripheral blood
- dengue virus
- patient reported